University of Leicester Researchers Have Provided New Data on Nephropathy (Therapy of IgA nephropathy: time for a paradigm change).

A recent report from researchers at the University of Leicester discusses the treatment of immunoglobulin A nephropathy (IgAN), a kidney disease that often leads to kidney failure. The researchers argue that IgAN should be treated as both a chronic kidney disease and an immunological disease. They highlight several agents that have received approval for the treatment of IgAN, including budesonide and sparsentan, and mention other agents that are being investigated. The researchers suggest that combination treatments may be more effective in halting the progression of IgAN and call for more trials to develop a comprehensive treatment strategy. [Extracted from the article]